Alkhunaizi Ahd, Melamed Nir, Hladunewich Michelle A
aDivision of Nephrology, Department of Medicine bDepartment of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Curr Opin Nephrol Hypertens. 2015 May;24(3):252-9. doi: 10.1097/MNH.0000000000000119.
This article reviews the available literature about the incidence, outcomes, and the management of pregnancy in women with advanced chronic kidney disease (CKD) and end-stage renal disease (ESRD) who require renal replacement therapy.
Pregnancy in women with advanced CKD and ESRD can result in serious adverse maternal and fetal outcomes, but improved outcomes have been noted in recent years, likely secondary to intensified dialysis regimens. More intensive dialysis allows for the gentle removal of water, solutes, and uremic toxins, which theoretically results in near-normal maternal renal physiology, an improvement in placental blood flow, and therefore a better environment for fetal growth and development. As management remains complex, a close joint collaboration between the high-risk obstetrical team and nephrology is essential.
Pregnancy on dialysis is becoming a viable option for women with advanced CKD and ESRD who do not have immediate access to transplantation.
本文回顾了有关晚期慢性肾脏病(CKD)和终末期肾病(ESRD)且需要肾脏替代治疗的女性患者妊娠的发生率、结局及管理的现有文献。
晚期CKD和ESRD女性患者妊娠可能导致严重的母婴不良结局,但近年来结局有所改善,这可能归因于强化透析方案。更强化的透析能够温和地清除水分、溶质和尿毒症毒素,理论上可使母体肾脏生理功能接近正常,改善胎盘血流,从而为胎儿生长发育创造更好的环境。由于管理仍然复杂,高危产科团队与肾脏病科密切合作至关重要。
对于无法立即接受移植的晚期CKD和ESRD女性患者,透析期间妊娠正成为一个可行的选择。